{"name":"Meso Scale Diagnostics","slug":"meso","ticker":"Private","exchange":"Private","domain":"mesoscale.com","description":"Meso Scale Diagnostics is a private company specializing in diagnostics and life science tools. They focus on developing innovative solutions for various therapeutic areas, including immunoassays and multiplexing technologies. Their products are used in research and clinical settings, providing valuable insights for disease diagnosis and treatment. As a private company, Meso Scale Diagnostics does not publicly disclose detailed financial information, but they are recognized as a leader in the diagnostics industry.","hq":"Rockville, MD","founded":0,"employees":"","ceo":"Jacob N. Wohlstadter","sector":"Diagnostics / Life Science Tools","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"Private (~$5B est.)","metrics":{"revenue":450000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-02-01","type":"deal","headline":"Meso Scale Diagnostics Acquires New Multiplexing Technology","summary":"Meso Scale Diagnostics acquired a new multiplexing technology to enhance their product offerings and expand their presence in the diagnostics market.","drugName":"","sentiment":"positive"},{"date":"2022-08-15","type":"regulatory","headline":"Meso Scale Diagnostics Receives FDA Clearance for New Assay","summary":"Meso Scale Diagnostics received FDA clearance for a new assay, expanding their product portfolio and capabilities in the diagnostics market.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNTjZsMDItdVo4blcyRzBwRVBJS0VsZXltSm5DaUpreG5MN05Ham1jUlVMWnVodU5sUElSSHhoQVdDYWRTOWpGbVEwZ25LZWFnWFN6em5Yb3hCTG9yQUctRHNVR2p2YTBUT0xDc2d6bWN3dnNXclE3bWUzX3hJYWVCaFdvRkFqOUxfZ0ExLXhMNW10NWxNOE9XWUstNUI?oc=5","date":"2016-11-14","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"With Biomarkers, Don’t Trust, Just Verify - Genetic Engineering and Biotechnology News","headline":"With Biomarkers, Don’t Trust, Just Verify","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":4,"keyCompetitors":["Abbott Laboratories","Siemens Healthineers","Roche Diagnostics"],"therapeuticFocus":["Immunology","Oncology"],"financials":null,"yahoo":null}